Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diane L Persons

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
Archives of Pathology & Laboratory Medicine|March 8, 2006
HER-2 fluorescence in situ hybridization: results from the survey program of the College of American PathologistsDiane L Persons, Raymond R Tubbs, Linda D Cooley, et al.
Archives of Pathology & Laboratory Medicine|November 29, 2002
Proficiency testing for laboratories performing fluorescence in situ hybridization with chromosome-specific DNA probesJames T Mascarello, Arthur R Brothman, Keri Davison, et al.
Archives of Pathology & Laboratory Medicine|July 13, 2006
Cytogenetic heteromorphisms: survey results and reporting practices of giemsa-band regions that we have pondered for yearsArthur R Brothman, Nancy R Schneider, Irene Saikevych, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2011
College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysisArthur R Brothman, Michelle M Dolan, Barbara K Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patientsLynn G Dressler, Donald A Berry, Gloria Broadwater, et al.
NPJ Breast Cancer|May 1, 2020
BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progressionHanan S Elsarraj, Yan Hong, Darlene Limback, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
Archives of Pathology & Laboratory Medicine|March 8, 2006
HER-2 fluorescence in situ hybridization: results from the survey program of the College of American PathologistsDiane L Persons, Raymond R Tubbs, Linda D Cooley, et al.
Archives of Pathology & Laboratory Medicine|November 29, 2002
Proficiency testing for laboratories performing fluorescence in situ hybridization with chromosome-specific DNA probesJames T Mascarello, Arthur R Brothman, Keri Davison, et al.
Archives of Pathology & Laboratory Medicine|July 13, 2006
Cytogenetic heteromorphisms: survey results and reporting practices of giemsa-band regions that we have pondered for yearsArthur R Brothman, Nancy R Schneider, Irene Saikevych, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|June 3, 2011
College of American Pathologists/American College of Medical Genetics proficiency testing for constitutional cytogenomic microarray analysisArthur R Brothman, Michelle M Dolan, Barbara K Goodman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 5, 2005
Comparison of HER2 status by fluorescence in situ hybridization and immunohistochemistry to predict benefit from dose escalation of adjuvant doxorubicin-based therapy in node-positive breast cancer patientsLynn G Dressler, Donald A Berry, Gloria Broadwater, et al.
NPJ Breast Cancer|May 1, 2020
BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progressionHanan S Elsarraj, Yan Hong, Darlene Limback, et al.
Pageof 3